drugset / Trial / NCT01275560

Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ?

NCT01275560 ↗

Phase 3 Completed 16 enrolled University Hospital, Rouen
RandomizedParallel-groupOpen-labelTreatment

Summary

The objectives of this work are: 1/to estimate the frequency of a positive glucose breath test in favour of a small intestinal bacterial overgrowth in a population of patients consulting for gaz incontinence by comparison to a population of control subjects; 2/to estimate versus a conventional treatment the efficiency of an antibiotic treatment; in case of small intestinal bacterial overgrowth diagnosed by the glucose breath test, to improve gaz incontinence

Timeline

Start
2011-01
Primary completion
2015-06
Completion
2015-06

Outcome

Met primary endpoint

paper The relative reduction in flatus incontinence episodes was significantly higher in the metronidazole than in the SC group (66.8±34.8% vs. 25±50%, P = 0.03), PMID 28763464 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Activated Charcoal Other / unclassified — —
Subject Metronidazole Small molecule 500 mg Oral
Comparator Simethicone Other / unclassified — —

Indications